E-LIB Suche - Ergebnisse für: Berger, Dan M.

1

Discovery and optimization of 7-aminofuro[2,3-c]pyridine in..:

Hornberger, Keith R. ; Berger, Dan M. ; Crew, Andrew P....
Bioorganic & Medicinal Chemistry Letters. 23 (2013) 16 - p. 4517-4522 , 2013

Link: https://doi.org/10.1016/..

2

Structure-based design of isoindoline-1,3-diones and 2,3-di..:

Wang, Xiaolun ; Salaski, Edward J. ; Berger, Dan M....
Bioorganic & Medicinal Chemistry Letters. 21 (2011) 23 - p. 6941-6944 , 2011

Link: https://doi.org/10.1016/..

3

Synthesis and biological evaluation of tricyclic anilinopyr..:

Crombie, Aimee L. ; Sum, Fuk-Wah ; Powell, Dennis W....
Bioorganic & Medicinal Chemistry Letters. 20 (2010) 12 - p. 3821-3825 , 2010

Link: https://doi.org/10.1016/..

4

Indazolylpyrazolopyrimidine as Highly Potent B-Raf Inhibito..:

Wang, Xiaolun ; Berger, Dan M. ; Salaski, Edward J....
Journal of Medicinal Chemistry. 53 (2010) 21 - p. 7874-7878 , 2010

Link: https://doi.org/10.1021/..

5

Dramatic Effect of Solvent Hydrogen Bond Basicity on the Re..:

Wang, Xiaolun ; Salaski, Edward J. ; Berger, Dan M..
Organic Letters. 11 (2009) 24 - p. 5662-5664 , 2009

Link: https://doi.org/10.1021/..

6

Non-hinge-binding pyrazolo[1,5-a]pyrimidines as potent B-Ra..:

Berger, Dan M. ; Torres, Nancy ; Dutia, Minu...
Bioorganic & Medicinal Chemistry Letters. 19 (2009) 23 - p. 6519-6523 , 2009

Link: https://doi.org/10.1016/..

7

Novel pyrazolopyrimidines as highly potent B-Raf inhibitors:

Di Grandi, Martin J. ; Berger, Dan M. ; Hopper, Darrin W....
Bioorganic & Medicinal Chemistry Letters. 19 (2009) 24 - p. 6957-6961 , 2009

Link: https://doi.org/10.1016/..

8

Lead identification to generate 3-cyanoquinoline inhibitors..:

Miller, Lori M. ; Mayer, Scott C. ; Berger, Dan M....
Bioorganic & Medicinal Chemistry Letters. 19 (2009) 1 - p. 62-66 , 2009

Link: https://doi.org/10.1016/..

9

Discovery of highly potent and selective type I B-Raf kinas..:

Wang, Xiaolun ; Berger, Dan M. ; Salaski, Edward J....
Bioorganic & Medicinal Chemistry Letters. 19 (2009) 23 - p. 6571-6574 , 2009

Link: https://doi.org/10.1016/..

10

4-Anilino-7-alkenylquinoline-3-carbonitriles as potent MEK1..:

Berger, Dan M. ; Dutia, Minu ; Powell, Dennis...
Bioorganic & Medicinal Chemistry. 16 (2008) 20 - p. 9202-9211 , 2008

Link: https://doi.org/10.1016/..

11

Observation of differential reactivity of cyclic amines in ..:

Hopper, Darrin W. ; Dutia, Minu ; Berger, Dan M..
Tetrahedron Letters. 49 (2008) 1 - p. 137-140 , 2008

Link: https://doi.org/10.1016/..

12

Carbon‐14 labelling of 3‐cyanoquinolines:

Olszewski, John D. ; Berger, Dan M. ; May, Michael K.
Journal of Labelled Compounds and Radiopharmaceuticals. 50 (2007) 5-6 - p. 578-579 , 2007

Link: https://doi.org/10.1002/..

13

4-Anilino-7,8-dialkoxybenzo[g]quinoline-3-carbonitriles as ..:

Berger, Dan M. ; Dutia, Minu ; Birnberg, Gary...
Journal of Medicinal Chemistry. 48 (2005) 19 - p. 5909-5920 , 2005

Link: https://doi.org/10.1021/..

14

4-Anilino-6,7-dialkoxyquinoline-3-carbonitrile Inhibitors o..:

Wissner, Allan ; Berger, Dan M. ; Boschelli, Diane H....
Journal of Medicinal Chemistry. 43 (2000) 17 - p. 3244-3256 , 2000

Link: https://doi.org/10.1021/..

15

'Drivin' with your eyes closed': Results from an internatio..:

Goethel, Daniel R. ; Berger, Aaron M. ; Hoyle, Simon D....
Fish and Fisheries. 25 (2024) 3 - p. 471-490 , 2024

Link: https://doi.org/10.1111/..